LAROSA JOSEPH J (SVP General Counsel and Secret) exercised options at REGENERON PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/24/2025ACC: 0001238303-25-000005
Officer· SVP General Counsel and Secret
Since Dec 2018
-12.69K
Net shares
Net seller
$9.35M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
14.45K acquired · 27.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.45K
Price / share
$555.67
Trade value
$8.03M
% of position
68.6%
11/20/2025
21.07K→35.52K
Common Stock
Direct
Shares
−12.69K
Price / share
$736.77
Trade value
$9.35M
% of position
35.7%
11/20/2025
35.52K→22.84K
Total
Net shares
+1.76K
Net value
-$1.32M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2025 | M · Option Exercise | +14.45K | $555.67 | $8.03M | 68.6% | 21.07K | 35.52K |
| Common Stock Direct | 11/20/2025 | F · Tax Withholding | −12.69K | $736.77 | $9.35M | 35.7% | 35.52K | 22.84K |
| Total | +1.76K | -$1.32M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
14.45K shares
Shares
−14.45K
Strike price
555.67
Held after
0.00
Exercisable
—
11/20/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock14.45K shares | 11/20/2025 | M · Option Exercise | −14.45K | 555.67 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned395.00
Common Stock
IndirectShares owned9K
Common Stock
IndirectShares owned9K
Total
18.39K indirect18.39K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 395.00 | Indirect |
| Common Stock | 9K | Indirect |
| Common Stock | 9K | Indirect |
| Total | 18.39K | 18.39K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported